Table 2.
Results of the major Western series of HCC treated by MWA, RFA, or IRE
| Author, year [reference] | Number of patients/nodules | Tumor size (cm)* | CAR | LRR | 1-Y DFS | 5-Y DFS | 1-Y OS | 5-Y OS |
|---|---|---|---|---|---|---|---|---|
| Niessen, 2016 [32] | IRE: 34/65 | IRE: 2.4; 0.2–7.1 | IRE: 81.5% | IRE: 35% | n.a. | n.a. | n.a. | n.a. |
| Cannon, 2013 [33] | IRE: 14/18 | IRE: 2.1; 1.3–4.5 | IRE: 83% | IRE: 50% | n.a. | n.a. | n.a. | n.a. |
| Cheung, 2013 [34] | IRE: 11/18 | IRE: 2.0; 1.0–6.1 | IRE: 72% | IRE: 0% | RFA: 96% | n.a. | n.a. | n.a. |
| MWA: 97% | ||||||||
| Vogl, 2015 [31] | RFA: 25/32 | RFA: 3.2; 0.8–4.5 | RFA: 84% | RFA: 3% | n.a. | n.a | RFA: 100% | n.a. |
| MWA: 28/36 | MWA: 3.6; 0.9–5 | MWA: 89% | MWA: 3% | MWA: 100% | ||||
| Groeschl, 2014 [35] | MWA: 139 | MWA: 2.6; 0.7–6 | MWA: 94% | MWA: 10% | n.a. | MWA: 7% | n.a. | MWA: 19% |
| N'Kontcho, 2009 [36] | RFA: 235 | RFA: 2.92; ±1** | RFA: 95% | RFA: 11% | n.a. | RFA: 32% | n.a. | RFA: 30% |
CAR=complete ablation rate; LRR=local recurrence rate; n.a.= not available.
*
Values are the median and range;
**
Values are the mean and standard deviation.